Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637312 · ClinicalTrials.gov registry record · NA
Advent™ Cervical Disc Versus ACDF for Treatment of One Level Degenerative Disc Disease (IDE Study)
A NA study, sponsored by Orthofix.
- Terminated
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT00637312: Clinical Trial NA study, sponsored by Orthofix.
NCT00637312 is a NA study that was terminated before completion, run by Orthofix. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00637312, a NA study, was terminated before completion, sponsored by Orthofix.
- TERMINATED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the safety and effectiveness of the Advent™ Cervical Disc compared to Anterior Cervical Discectomy and Fusion (ACDF) in treating degenerative disc disease at a single-level in the cervical spine (from C3 to C7) following cervical discectomy in skeletally mature patients (at least 18 years of age).
Interventions
- DEVICE Cervical Artificial Disc (Advent™ Cervical Disc)
- DEVICE Hallmark™ Anterior Cervical Plate System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-02 |
| Phase | NA |
Why NCT00637312 stopped before completion
NCT00637312 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Cervical Artificial Disc (Advent™ Cervical Disc) is the first listed.
NCT00637312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00637312 about?
NCT00637312 is a clinical study titled "Advent™ Cervical Disc Versus ACDF for Treatment of One Level Degenerative Disc Disease (IDE Study)". The purpose of this study is to establish the safety and effectiveness of the Advent™ Cervical Disc compared to Anterior Cervical Discectomy and Fusion (ACDF) in treating degenerative disc disease at a single-level in the cervical spine (from C3 to C7) following cervical discectomy in skeletally mat...
What is the current status of trial NCT00637312?
This trial is currently terminated. It is a NA study. The enrollment target is 108 participants. The study started on 2008-03. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00637312?
The interventions under investigation include: Cervical Artificial Disc (Advent™ Cervical Disc) (DEVICE), Hallmark™ Anterior Cervical Plate System (DEVICE).
Who is sponsoring clinical trial NCT00637312?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00637312's enrollment target sits among peer trials
108 825th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia